Volume 80, Issue 4 pp. 533-538
Experimental Cancer

Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue

Jennie L. Finch

Jennie L. Finch

Department of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia

Search for more papers by this author
John Miller

John Miller

Department of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia

Department of Urology, The Queen Elizabeth Hospital, Woodville, South Australia

Search for more papers by this author
James O. Aspinall

James O. Aspinall

Department of Urology, Royal Adelaide Hospital, Adelaide, South Australia

Search for more papers by this author
Prudence A. Cowled

Corresponding Author

Prudence A. Cowled

Department of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia

Department of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville Road, Woodville, South Australia, 5011, Australia. Fax: (61) 8-8222-6028.Search for more papers by this author

Abstract

The human uroplakin 1B (UPK1B) gene codes for a structural protein which is a terminal differentiation component of the asymmetric unit membrane on the apical surface of the mammalian bladder. UPK1B is a member of the tetraspan family of proteins, many of which have de-regulated patterns of expression in cancer. Using polymerase-chain-reaction techniques, we have cloned a partial human UPK1B cDNA which codes for the putative full open reading frame for the UPK1B protein. The deduced human UPK1B protein sequence has 92% and 93% amino-acid homology with bovine UPK1b and mink TI1 proteins respectively. Using Northern analysis, we show that the human UPK1B gene is highly expressed in normal human urothelium. However, expression of UPK1B mRNA was undetectable or markedly reduced in 11 out of 16 samples of transitional-cell-bladder-carcinoma tissue and in all 5 bladder-carcinoma cell lines when compared with normal urothelial tissue. The molecular mechanism of down-regulation of RNA expression does not appear to involve gross gene rearrangements or allelic loss. Int. J. Cancer 80:533–538, 1999. © 1999 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.